ARx (Drug Delivery Systems)
As a leading industry expert of drug-loaded dissolvable film and patch delivery systems, ARx is an innovative development and manufacturing partner for novel drug products. ARx’s work expands dosage form possibilities for new or existing drug products by enhancing bioavailability and increasing patient compliance. The result is enriched patient well-being through robust drug delivery systems.
ARx focuses primarily on transdermal and transmucosal routes of administration to leverage our proven expertise in Quality by Design (QbD)-based controls, formulation, analytical testing, mixing, coating and drying. Our drug delivery systems and expertise include:
oral, buccal, sublingual and mucosal thin films, and transdermal patches.
As an extension of our customers’ project teams, ARx builds a collaborative development plan based upon the needs of the filing strategy, QbD principles and critical milestones. Project experience spans a range of therapies in support of FDA ANDA’s, 505(b)(1) and 505(b)(2) NDA’s, in addition to support for filings with global agencies around the world.
Learn more about partnering with ARx from concept to commercialization on our new ARx website: